vialroom

#retatrutide 2025-04-13

Sunday12 messages4 participantstimes are UTC
Highlights from this day
  • homa_ir_hugo — stopped for 22 months and restarted at half my old dose, the ramp was easier second time 23:01
  • void_volume — my resting rate went up 9 bpm in the first month and came back most of the way by month 25 23:31
  • no_appetite_nia — energy expenditure isnt something i could feel, though my sleep tracker disagreed with me 23:42
HI

is there any long term safety data at all or is it phase 2 and hope

stopped for 22 months and restarted at half my old dose, the ramp was easier second time

EE

does the glucagon arm explain the heart rate or is that unrelated

research use only

sat at 2 for 2 months rather than climbing and it kept working, so i never went up

HI

blood pressure stayed flat for me while heart rate moved, which i didnt expect

VV

mine went up too

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
😂1🔥4🎉13
VV

my resting rate went up 9 bpm in the first month and came back most of the way by month 25

10😂3🎉4
HI

quick one did the phase 2 result actually come in higher than the tirzepatide numbers

NA

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me